Optimal antithrombotic treatment of patients after coronary artery bypass grafting

Optimal antithrombotic treatment of patients after coronary artery bypass grafting

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400095060

Enrollment

Unknown

Registered

2024-12-31

Start date

2025-01-01

Completion date

Unknown

Last updated

2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary atherosclerotic heart disease

Interventions

Patients were grouped according to different anticoagulation or antiplatelet regimens:None

Sponsors

First Affiliated Hospital, School of Medicine, Zhejiang University

Lead Sponsor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing CABG combined with anticoagulant therapy from January 1, 2012 to January 1, 2024 were included

Exclusion criteria

Exclusion criteria: Follow-up data were incomplete

Design outcomes

Primary

Measure	Time frame
None;	—

Countries

China

Contacts

Public Contactzhang heng

First Affiliated Hospital, School of Medicine, Zhejiang University

hengzhang99@163.com+86 182 6804 8279

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026